149 related articles for article (PubMed ID: 15195106)
1. Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
Fowler LJ; Lovell MO; Izbicka E
Mod Pathol; 2004 Aug; 17(8):1012-20. PubMed ID: 15195106
[TBL] [Abstract][Full Text] [Related]
2. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
[TBL] [Abstract][Full Text] [Related]
3. SELDI-TOF-MS proteomics of breast cancer.
Clarke CH; Buckley JA; Fung ET
Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.
Sauter ER; Shan S; Hewett JE; Speckman P; Du Bois GC
Int J Cancer; 2005 May; 114(5):791-6. PubMed ID: 15609313
[TBL] [Abstract][Full Text] [Related]
5. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
[TBL] [Abstract][Full Text] [Related]
6. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
7. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
8. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
9. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
[TBL] [Abstract][Full Text] [Related]
10. SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Zeidan BA; Townsend PA
Breast Cancer Res; 2008; 10(3):107. PubMed ID: 18644101
[TBL] [Abstract][Full Text] [Related]
11. A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer.
Noble JL; Dua RS; Coulton GR; Isacke CM; Gui GP
Eur J Cancer; 2007 Nov; 43(16):2315-20. PubMed ID: 17904354
[TBL] [Abstract][Full Text] [Related]
12. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.
Mendrinos S; Nolen JD; Styblo T; Carlson G; Pohl J; Lewis M; Ritchie J
Cancer; 2005 Jun; 105(3):178-83. PubMed ID: 15822128
[TBL] [Abstract][Full Text] [Related]
13. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
Gonçalves A; Bertucci F; Birnbaum D; Borg JP
Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
[TBL] [Abstract][Full Text] [Related]
14. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
15. Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.
Gast MC; van Dulken EJ; van Loenen TK; Kingma-Vegter F; Westerga J; Flohil CC; Knol JC; Jimenez CR; van Gils CH; Wessels LF; Schellens JH; Beijnen JH
Int J Biol Markers; 2009; 24(3):130-41. PubMed ID: 19787623
[TBL] [Abstract][Full Text] [Related]
16. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
17. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.
Paweletz CP; Trock B; Pennanen M; Tsangaris T; Magnant C; Liotta LA; Petricoin EF
Dis Markers; 2001; 17(4):301-7. PubMed ID: 11790897
[TBL] [Abstract][Full Text] [Related]
18. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]